“As a co-founder and editor of a company that reviewed FDA-approved drugs, I found it almost impossible to maintain currency, not only on recently approved agents, but especially those in the pipeline. To do so, I highly recommend THE PHARMACEUTICAL PIPELINE TRACKER; there are few drug information resources on my "must review" list but this has become one of them. It not only includes new agents but those in some stage of review which aids both with therapeutic as well as formulary considerations. Its' salient quality is the concise nature of the information. It allows a relatively rapid review of a drug's comparative efficacy today as well as what to expect in the future.”
Dennis Cada, PharmD, FASHP, FASCP
Co-founder and Editor, The Formulary
Consulting Editor, Hospital Pharmacy
Dennis Cada, PharmD, FASHP, FASCP
Co-founder and Editor, The Formulary
Consulting Editor, Hospital Pharmacy
